| Hazard assessment of polymeric nanobiomaterials for drug delivery: what can we learn from literature so far S Jesus, M Schmutz, C Som, G Borchard, P Wick, O Borges Frontiers in bioengineering and biotechnology 7, 261, 2019 | 78 | 2019 |
| Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety AT Chatzitaki, S Jesus, C Karavasili, D Andreadis, DG Fatouros, O Borges International journal of pharmaceutics 589, 119776, 2020 | 75 | 2020 |
| Chitosan nanoparticles: Shedding light on immunotoxicity and hemocompatibility S Jesus, AP Marques, A Duarte, E Soares, JP Costa, M Colaço, ... Frontiers in bioengineering and biotechnology 8, 100, 2020 | 73 | 2020 |
| Sonication-assisted layer-by-layer assembly for low solubility drug nanoformulation AC Santos, P Pattekari, S Jesus, F Veiga, Y Lvov, AJ Ribeiro ACS applied materials & interfaces 7 (22), 11972-11983, 2015 | 58 | 2015 |
| A methodological safe-by-design approach for the development of nanomedicines M Schmutz, O Borges, S Jesus, G Borchard, G Perale, M Zinn, ... Frontiers in bioengineering and biotechnology 8, 258, 2020 | 56 | 2020 |
| Exosomes as adjuvants for the recombinant hepatitis B antigen: First report S Jesus, E Soares, MT Cruz, O Borges European Journal of Pharmaceutics and Biopharmaceutics 133, 1-11, 2018 | 55 | 2018 |
| Poly (D, L-Lactic Acid) nanoparticle size reduction increases its immunotoxicity J Da Silva, S Jesus, N Bernardi, M Colaço, O Borges Frontiers in Bioengineering and Biotechnology 7, 137, 2019 | 48 | 2019 |
| Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles S Jesus, E Soares, J Costa, G Borchard, O Borges International journal of pharmaceutics 504 (1-2), 59-69, 2016 | 46 | 2016 |
| Oral hepatitis B vaccine: chitosan or glucan based delivery systems for efficient HBsAg immunization following subcutaneous priming E Soares, S Jesus, O Borges International Journal of Pharmaceutics 535 (1-2), 261-271, 2018 | 43 | 2018 |
| Synthesis and controlled curcumin supramolecular complex release from pH-sensitive modified gum-arabic-based hydrogels AP Gerola, DC Silva, S Jesus, RA Carvalho, AF Rubira, EC Muniz, ... RSC advances 5 (115), 94519-94533, 2015 | 40 | 2015 |
| Poly-ε-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen S Jesus, E Soares, G Borchard, O Borges Nanomedicine 12 (19), 2335-2348, 2017 | 33 | 2017 |
| Chitosan plus compound 48/80: formulation and preliminary evaluation as a hepatitis B vaccine adjuvant D Bento, S Jesus, F Lebre, T Gonçalves, O Borges Pharmaceutics 11 (2), 72, 2019 | 31 | 2019 |
| Adjuvant activity of poly-ε-caprolactone/chitosan nanoparticles characterized by mast cell activation and IFN-γ and IL-17 production S Jesus, E Soares, G Borchard, O Borges Molecular pharmaceutics 15 (1), 72-82, 2018 | 30 | 2018 |
| Chitosan: β-glucan particles as a new adjuvant for the hepatitis B antigen E Soares, S Jesus, O Borges European Journal of Pharmaceutics and Biopharmaceutics 131, 33-43, 2018 | 26 | 2018 |
| Freeze dried chitosan/poly-ε-caprolactone and poly-ε-caprolactone nanoparticles: evaluation of their potential as DNA and antigen delivery systems S Jesus, G Borchard, O Borges J Genet Syndr Gene Ther 4 (164), 2, 2013 | 22 | 2013 |
| Optimization of chitosan-α-casein nanoparticles for improved gene delivery: characterization, stability, and transfection efficiency J Panão Costa, S Carvalho, S Jesus, E Soares, AP Marques, O Borges AAPS PharmSciTech 20, 1-12, 2019 | 19 | 2019 |
| The inclusion of chitosan in poly-ε-caprolactone nanoparticles: impact on the delivery system characteristics and on the adsorbed ovalbumin secondary structure S Jesus, EH Fragal, AF Rubira, EC Muniz, AJM Valente, O Borges AAPS PharmSciTech 19, 101-113, 2018 | 18 | 2018 |
| Chitosan-based nanoparticles as a hepatitis B antigen delivery system F Lebre, D Bento, S Jesus, O Borges Methods in Enzymology 509, 127-142, 2012 | 16 | 2012 |
| Safe-by-design of glucan nanoparticles: size matters when assessing the immunotoxicity M Colaço, AP Marques, S Jesus, A Duarte, O Borges Chemical Research in Toxicology 33 (4), 915-932, 2020 | 15 | 2020 |
| Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride AT Chatzitaki, S Jesus, C Karavasili, D Andreadis, DG Fatouros, O Borges vitro, 2020 | 12 | 2020 |
